http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008157408-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ad7db51775730aa88bfb46e8c6b4ab71
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_01a191700ae0bd1cec98a894cc14e43c
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-27
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-27
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
filingDate 2008-06-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a0dd80aa08c13b4fe10cfb8f0f8be66a
publicationDate 2009-02-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2008157408-A3
titleOfInvention Use of prodrugs of gaba analogs, antispasticity agents, and prodrugs of gaba b receptor agonists for treating spasticity
abstract Methods of treating spasticity by administering a colonically absorbable prodrug of a GABA analog having antispastic activity that is not directly mediated by the GABAB receptor, optionally in combination with an antispasticity agent or a colonically absorbable prodrug of a GABAB receptor agonist are disclosed. In particular, methods of treating spasticity by administering a colonically absorbable prodrug of gabapentin or a colonically absorbable prodrug of pregabalin, in combination with a colonically absorbable prodrug of R-baclofen are disclosed.
priorityDate 2007-06-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005019163-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0222568-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1178034-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005027850-A2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129364554
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419533932
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID119
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID44602
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419487869
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415725959
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399472
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3446
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5486971
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419535566
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127479071
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399567

Total number of triples: 31.